Pharmacists News
- Pfizer Says COVID-19 Vaccine Response Robust in Young Children
- SGLT-2 inhibitors as First-Line Therapy in Type 2 Diabetes?
- Cancer Coalition Aims to Boost Access to Meds in Poorer Countries
- Postpolypectomy Bleeding: Does Prophylactic Clipping Reduce Risk?
- Combining Allergic Rhinitis Treatments May Improve Symptoms
- Zolpidem Restrictions: How Are General Practitioners Coping?
- Adolescents With Food Allergies Share Common Concerns
- How to Manage Drug Interactions With Paxlovid for COVID
- Allergen-Specific Immunotherapy During Pregnancy Appears Safe for Babies
- FDA Approves First Drug for Eosinophilic Esophagitis
- Alert Baricitinib Backed for Approval for Alopecia Areata in the EU
- Vitamins, OTC Drugs May Interact With HIV Antiretroviral Therapy
- AACE 2022 Debate Continues on Combination Therapy for Hypothyroidism
- Prostate Cancer Survival: Enzalutamide Edges Out Abiraterone
- CDC Signs Off on COVID Boosters in Children Ages 5-11
- Rabies: CDC Updates PrEP Vaccination Recommendations
- Experts Urge Stopping Melanoma Trial Because of Failure and Harm
- NeoChemo Preserves Rectum in Half of Patients With Rectal Cancer
- ACMS 2022 Post-Mohs Bleeding Risk in Patients on Ibrutinib for CLL Studied
- EuroPCR 2022 One-Month DAPT Enough for Complex PCI if Bleeding Risk High